Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 1/20 | 0.56 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.53 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.53 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.53 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.53 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.53 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.53 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.53 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.53 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.53 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.53 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.53 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | PPARG | P37231 | 2/20 | 0.50 |
| ▸ | PPARA | Q07869 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27563963 | 0.94 | TRPA1 (0.57) | GRIK1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL3162017 | 0.94 | TRPA1 (0.57) | GRIK1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL3170929 | 0.94 | TRPA1 (0.57) | GRIK1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL8667618 | 0.92 | TRPA1 (0.59) | GRIK1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL5155795 | 0.92 | TRPA1 (0.59) | GRIK1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL8663794 | 0.92 | TRPA1 (0.59) | GRIK1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL864212 | 0.92 | TRPA1 (0.59) | GRIK1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL8669194 | 0.92 | TRPA1 (0.59) | GRIK1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL233440 | 0.88 | CNR2 (0.50) | SMN1; SMN2PPARGPPARAKEAP1 | |
| SCHEMBL360781 | 0.88 | CNR2 (0.50) | SMN1; SMN2PPARGPPARAKEAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024107938-A2 | POLYPHENOL LIPID NANOPARTICLES AND METHODS OF USE | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2024-05-23 | — | — | WO | claimed |
| CN-117339390-A | Synergistic extraction system and extraction process for extracting and separating boron isotopes | 中国科学院过程工程研究所 | 2024-01-05 | — | — | CN | claimed |
| EP-2188375-A1 | MUTANT OF PROPIONYL-COA TRANSFERASE FROM CLOSTRIDIUM PROPIONICUM AND PREPARING METHOD FOR PLA OR PLA COPOLYMER USING THE SAME | LG Chem. Ltd. (KR) | 2010-05-26 | — | — | EP | claimed |
| WO-2009022797-A1 | MUTANT OF PROPIONYL-COA TRANSFERASE FROM CLOSTRIDIUM PROPIONICUM AND PREPARING METHOD FOR PLA OR PLA COPOLYMER USING THE SAME | LG CHEM, LTD. (KR) | 2009-02-19 | — | — | WO | claimed |
| WO-2008113190-A1 | METHOD FOR THE PRODUCTION OF R-HYDROXYCARBOXYLIC ACIDS | EMPA EIDGENÖSSISCHE MATERIALPRÜFUNGS- UND FORSCHUNGSANSTALT (CH) | 2008-09-25 | — | — | WO | claimed |
| US-12628821-B2 | Agricultural adjuvant | ORO AGRI INC. (US) | 2026-05-19 | — | — | US | disclosed |
| US-20240355451-A1 | METHODS FOR IMPROVING GUT MICROBIOTA DIVERSITY | NESTLE SA (CH) | 2024-10-24 | — | — | US | disclosed |
| EP-4391834-A1 | METHODS FOR IMPROVING GUT MICROBIOTA DIVERSITY | Société des Produits Nestlé S.A. (CH) | 2024-07-03 | — | — | EP | disclosed |
| WO-2024107938-A2 | POLYPHENOL LIPID NANOPARTICLES AND METHODS OF USE | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2024-05-23 | — | — | WO | disclosed |
| US-20240108642-A1 | GLYCAN THERAPEUTIC COMPOSITIONS AND RELATED METHODS THEREOF | DSM NUTRITIONAL PRODUCTS, LLC | 2024-04-04 | — | — | US | disclosed |
| CN-117813017-A | Method for improving intestinal microbiota diversity | 雀巢产品有限公司 | 2024-04-02 | — | — | CN | disclosed |
| EP-4324482-A2 | EXCIPIENT COMPOUNDS FOR BIOPOLYMER FORMULATIONS | Comera Life Sciences, Inc. (US) | 2024-02-21 | — | — | EP | disclosed |
| EP-3071235-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | Kaleido Biosciences, Inc. (US) | 2016-09-28 | — | — | EP | disclosed |
| WO-2016122889-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | KALEIDO BIOSCIENCES, INC. (US) | 2016-08-04 | — | — | WO | disclosed |
| US-20160213702-A1 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | KALEIDO BIOSCIENCES, INC. (US) | 2016-07-28 | — | — | US | disclosed |
| CN-100381940-C | Polyhydroxyalkanoate containing amide group, sulfonic group, and sulfonate ester group, method for producing the same, and charge control agent, toner, image forming method, and image forming apparatu | CANON KK (JP) | 2008-04-16 | — | — | CN | disclosed |
| CN-1802610-A | Polyhydroxyalkanoate containing amide group, sulfonic acid group and sulfonate group, method for producing the same, and charge control agent, toner, image forming method and image forming apparatus | CANON KK (JP) | 2006-07-12 | — | — | CN | disclosed |
| US-20030072594-A1 | Binder resin containing novel polyhydroxyalkanoate, toner containing the binder resin, and image-forming method and image-forming apparatus which make use of the toner | CANON KABUSHIKI KAISHA (JP) | 2003-04-17 | — | — | US | disclosed |
| JP-2000309575-A | NOVEL HYDANTOIN DERIVATIVE AND PRODUCTION THEREOF | TAKEDA CHEM IND LTD | 2000-11-07 | — | — | JP | disclosed |
| EP-0816316-A1 | PROCESS FOR PRODUCING 1,2-ETHANEDIOL DERIVATIVES | NITTO CHEMICAL INDUSTRY CO., LTD. (JP) | 1998-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12628821-B2 | Agricultural adjuvant | NOTUM, ACHE, LRAT | GRIK1 1859/4885HDAC3 2621/4885HDAC1 2491/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.